A carregar...

Antibody drug-conjugates targeting the tumor vasculature: Current and future developments

Reducing the blood supply of tumors is one modality to combat cancer. Monoclonal antibodies are now established as a key therapeutic approach for a range of diseases. Owing to the ability of antibodies to selectively target endothelial cells within the tumor vasculature, vascular targeting programs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gerber, Hans-Peter, Senter, Peter D, Grewal, Iqbal S
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726597/
https://ncbi.nlm.nih.gov/pubmed/20069754
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!